Efficacy and safety of guselkumab in psoriasis patients who failed ustekinumab and/or anti‐ interleukin ‐17 treatment: A real‐life 52‐week retrospective study
Author:
Affiliation:
1. Section of Dermatology, Department of Clinical Medicine and Surgery University of Naples Federico II Napoli Italy
Publisher
Wiley
Subject
Dermatology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.14673
Reference20 articles.
1. Skin expression of IL-23 drives the development of psoriasis and psoriatic arthritis in mice
2. Psoriatic Arthritis
3. Psoriatic disease treatment nowadays: unmet needs among the “jungle of biologic drugs and small molecules”
4. Guselkumab: First Global Approval
5. IL-23 inhibitors for moderate-to-severe psoriasis
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Association between several immune response‐related genes and the effectiveness of biological treatments in patients with moderate‐to‐severe psoriasis;Experimental Dermatology;2024-01
2. Real‐world data show high efficacy of IL23 inhibitors guselkumab and risankizumab in psoriatic arthritis and difficult‐to‐treat areas;International Journal of Dermatology;2023-09-25
3. Safety of IL-23 p19 Inhibitors for the Treatment of Patients With Moderate-to-Severe Plaque Psoriasis: A Narrative Review;Advances in Therapy;2023-06-18
4. Guselkumab for treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and drug-survival for up to 148 weeks;Expert Opinion on Biological Therapy;2023-03-27
5. The feasibility of the use of monoclonal antibodies to interleukin 23 in the therapy of severe psoriasis with the eluding effect of genetically engineered biological drugs;Meditsinskiy sovet = Medical Council;2023-03-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3